Catalys Pacific News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Catalys Pacific LLC purchased a new position in shares of Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 721,962 shares of the company’s stock, valued at approximately $6,592,000. Phathom Pharmaceuticals accounts for about 6.2% of […]

Shares of HilleVax, Inc. (NASDAQ:HLVX – Get Free Report) gapped up prior to trading on Friday . The stock had previously closed at $12.02, but opened at $12.58. HilleVax shares last traded at $11.99, with a volume of 1,768 shares. Analyst Ratings Changes Separately, HC Wainwright reiterated a “buy” rating and issued a $28.00 price […]

Mineralys Therapeutics (NASDAQ:MLYS – Get Free Report)‘s stock had its “outperform” rating reissued by research analysts at Lifesci Capital in a research note issued on Tuesday, Zacks.com reports. Lifesci Capital also issued estimates for Mineralys Therapeutics’ FY2024 earnings at ($2.04) EPS. Mineralys Therapeutics Trading Down 0.5 % NASDAQ:MLYS opened at $12.78 on Tuesday. The stock […]

HilleVax, Inc. (NASDAQ:HLVX – Get Free Report) Director Aditya Kohli sold 6,000 shares of the business’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $18.66, for a total transaction of $111,960.00. Following the completion of the sale, the director now directly owns 825,776 shares of the […]

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report)’s share price was up 9.4% on Tuesday . The company traded as high as $10.65 and last traded at $10.16. Approximately 351,678 shares traded hands during mid-day trading, a decline of 54% from the average daily volume of 761,808 shares. The stock had previously closed at $9.29. […]